000 | 01977nam a22002297a 4500 | ||
---|---|---|---|
005 | 20220614122000.0 | ||
020 | _a9780128166758 | ||
040 |
_cHITLIB _erda |
||
050 |
_aQD321 _bCAR |
||
245 | 0 | 0 |
_aCarbohydrates in drug discovery and development : _bsynthesis and application / _cEdited by Vinod Kumar Tiwari |
264 |
_aSan Diego : _bElsevier, _c2020. |
||
300 |
_a716 pages : _bIllustrations |
||
336 |
_2rdacontent _atext _btxt |
||
337 |
_2rdamedia _aunmediated _bn |
||
338 |
_2rdacarrier _avolume _bnc |
||
500 | _aIncludes index | ||
505 | _a1. Recent trends and challenges on carbohydrate-based molecular scaffolding: general consideration toward impact of carbohydrates in drug discovery and development2. Heparin mimetics as tools for modulation of biology and therapy3. Bioactive C-glycosides inspired from natural products toward therapeutics4. 3-Deoxy-d-manno-oct-2-ulosonic acid (Kdo) derivatives in antibacterial drug discovery5. Sialic acid-containing molecules in drug discovery and development6. Glycan microarray: Toward drug discovery and development7. Recent developments in the synthesis of biologically relevant Iinositol derivatives8. Iminosugars in medicinal chemistry9. Carbohydrate-protein interactions: Enhancing multivalency effects through statistical rebinding10. Carbo-click in drug discovery and development: Opportunity and challenges11. Glycohybrids molecule in medicinal chemistry: Present status and future prospective12. Biologically active carbohydrate-containing macrocycles13. Carbohydrate-based antibiotics: Opportunities and challenges14. Carbohydrate-based anti-bacterial and anti-cancer vaccines15. Opportunity of plant oligosaccharides and polysaccharides in drug development16. N-acetylgalactosamine (GalNAc)-conjugates: Delivering oligonucleotide drugs to the liver | ||
650 | 0 |
_aCarbohydrates _xTherapeutic use. |
|
650 | 0 | _aPharmaceutical chemistry. | |
700 | 1 |
_aTiwari, Vinod Kumar _eEditor |
|
942 |
_2lcc _cBK |
||
999 |
_c2957 _d2957 |